CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Class A Preferred Stock [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Stockholders Equity Attributable To Cannabis Global Inc [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Aug. 31, 2020	$ 600	$ 2,708	$ 187	$ 4,618,168	$ (6,056,949)	$ (1,435,286)		$ (1,435,286)
Beginning Balance, Shares at Aug. 31, 2020	6,000,000	27,082,419	1,871,858
Stock based compensation		$ 3,400		179,600		183,000		183,000
Stock based compensation, Share		3,400,000
Proceeds from common stock subscriptions		$ 510	$ 90	(600)
Proceeds from common stock subscriptions, Shares		510,204	89,796
Common stock issued for investment		$ 7,222		642,778		650,000		650,000
Common stock issued for investment, Shares		7,222,222
Common stock issued in settlement of convertible notes payable and accrued interest		$ 1,500		28,500		30,000		30,000
Common stock issued in settlement of convertible notes payable and accrued interest, Shares		1,500,000
Effects of Par value adjustment		$ 24,372	1,683	(26,055)
Net Loss					(353,224)	(353,224)		(353,224)
Ending balance, value at Nov. 30, 2020	$ 600	$ 39,712	$ 1,960	5,442,391	(6,410,173)	(925,510)		(925,510)
Ending Balance, Shares at Nov. 30, 2020	6,000,000	39,714,845	1,961,654
Stock based compensation		$ 4,107	$ (600)	335,827		339,334		339,334
Stock based compensation, Share		4,106,543	(600,000)
Proceeds from common stock subscriptions		$ 6,517		384,483		391,000		391,000
Proceeds from common stock subscriptions, Shares		6,516,667
Common stock issued for investment		$ 12,820		2,209,355		2,222,175	3,849,293	6,071,468
Common stock issued for investment, Shares		12,820,297
Common stock issued in settlement of convertible notes payable and accrued interest		$ 3,047		213,682		216,729		216,729
Common stock issued in settlement of convertible notes payable and accrued interest, Shares		3,047,335
Derivative impact of conversions				276,975		276,975		276,975
Net Loss					(2,110,770)	(2,110,770)		(2,110,770)
Ending balance, value at Feb. 28, 2021	$ 600	$ 66,203	$ 1,360	8,862,713	(8,520,943)	409,933	3,849,293	4,259,226
Ending Balance, Shares at Feb. 28, 2021	6,000,000	66,205,687	1,361,654
Beginning balance, value at Aug. 31, 2021	$ 600	$ 84,938	$ 2,078	11,591,829	(13,891,788)	(2,212,343)	3,568,150	1,355,807
Beginning Balance, Shares at Aug. 31, 2021	6,000,000	84,940,028
Stock based compensation		$ 3,327		86,047		89,374		89,374
Stock based compensation, Share		3,326,790
Common stock issued in settlement of convertible notes payable and accrued interest		$ 124,188		933,554		1,057,742		1,057,742
Common stock issued in settlement of convertible notes payable and accrued interest, Shares		124,187,672
Derivative impact of conversions				1,273,832		1,273,832		1,273,832
Net Loss					379,705	379,705	(11,627)	368,078
Ending balance, value at Nov. 30, 2021	$ 600	$ 212,453	$ 2,078	13,885,262	(13,512,083)	588,310	3,556,523	4,144,833
Ending Balance, Shares at Nov. 30, 2021	6,000,000	212,454,490	2,079,654
Common stock issued in settlement of convertible notes payable and accrued interest		$ 195,388		371,671		567,059		567,059
Common stock issued in settlement of convertible notes payable and accrued interest, Shares		195,388,201
Common stock issued related to joint venture		$ 75,000		225,000		300,000		300,000
Common stock issued related to joint venture, Shares		75,000,000
Discount on convertible notes		$ 3,000		22,200		25,200		25,200
Discount on convertible notes, Shares		3,000,000
Common stock issued in exchange for exercise of warrants on a cashless basis		$ 23,300		(23,300)
Common stock issued in exchange for exercise of warrants on a cashless basis, Shares		23,300,000
Acquisition measurement period adjustment				1,729,253		1,729,253	1,076,707	2,805,960
Derivative impact of conversions				785,109		785,109		785,109
Net Loss					(503,424)	(503,424)	(193,701)	(697,125)
Ending balance, value at Feb. 28, 2022	$ 600	$ 509,141	$ 2,078	$ 16,995,195	$ (14,015,507)	$ 3,491,507	$ 4,439,529	$ 7,931,036
Ending Balance, Shares at Feb. 28, 2022	6,000,000	509,142,691	2,079,654

CANNABIS GLOBAL, INC. 10-Q